Martin's primary research interests is in: the role of PSMA PET/CT in high-risk prostate cancer, local cytoreductive therapy and metastasis-directed therapies for men with newly-diagnosed metastatic prostate cancer. He has a further interest in understanding how men make treatment decisions in prostate cancer, including the use of discrete choice experiments.